Review: Treatment of plaque psoriasis with an ointment formulation of the Januskinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. V1
2016
Related Papers
- → FDA approves tofacitinib for rheumatoid arthritis(2012)97 cited
- → Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies(2016)31 cited
- → The off-label uses profile of tofacitinib in systemic rheumatic diseases(2020)13 cited
- → P088 REAL-WORLD EXPERIENCE WITH TOFACITINIB FOR THE MANAGEMENT OF CROHN’S COLITIS(2020)2 cited
- → AB0344 FACTORS WHICH CONTRIBUTE PERSISTENCY AND OPTIMAL USE OF TOFACITINIB; LESSONS FROM LONG TERM DAILY CLINICAL USE OF TOFACITINIB(2020)